KRISTIN LE BEAU: Open Payments
NPI 1992092142 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 11 payments from 5 companies in 2025. Trend: 2023 $46 · 2024 $166 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 1 | $122 |
| Alkermes, Inc. | 5 | $92 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $29 |
| Lundbeck LLC | 1 | $16 |
Products named: BRIXADI, VIVITROL, INGREZZA, Wegovy, REXULTI.
Industry payments across NJ — which companies pay providers there.
